1190713-13-3

Upstream product

• 325685-75-4 4-Chloro-6-hydroxymethyl-2-phenylpyrimidine 
• 592-34-7 carbonochloridic acid, butyl ester 
• 1021703-38-7 4-{(S)-4-tert-butoxycarbonyl-2-[(6-chloro-2-phenyl-pyrimidine-4-carbonyl)-amino]-butyryl}-piperazine-1-carboxylic acid butyl ester 
• 1190713-19-9 Piperazine-1-carboxylic acid butyl ester hydrochloride salt 
• 1073554-07-0 piperazine-1,4-dicarboxylic acid tert-butyl ester butyl ester 
• 913952-59-7 6-chloro-2-phenylpyrimidine-4-carboxylic acid 
• 1019929-05-5 butyl (S)-4-(2-benzyloxycarbonylamino-4-tert-butoxycarbonylbutyryl)piperazine-1-carboxylate 
• 1019929-10-2 butyl (S)-4-(2-amino-4-tert-butoxycarbonylbutyryl)piperazine-1-carboxylate 
• 1190713-21-3 4-{(S)-4-tert-butoxycarbonyl-2-[(6-cyclopropyl-2-phenyl-pyrimidine-4-carbonyl)-amino]-butyryl}-piperazine-1-carboxylic acid butyl ester 

Relevant academic research and scientific papers

2-PHENYL-4-CYCLOPROPYL-PYRIMIDINE DERIVATIVES

The present invention relates to 2-phenyl-4-cyclopropyl-pyrimidine derivatives and their use as P2Y12 receptor antagonists in the treatment and/or prevention of peripheral vascular, of visceral-, hepatic- and renal-vascular, of cardiovascular a

2-PHENYL-4-CYCLOPROPYL-PYRIMIDINE DERIVATIVES

The present invention relates to 2-phenyl-4-cyclopropyl-pyrimidine derivatives and their use as P2Y12 receptor antagonists in the treatment and/or prevention of peripheral vascular, of visceral-, hepatic- and renal-vascular, of cardiovascular a